Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling

65.3BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1011371077
CUSIP
101137107
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
17.90
PEG Ratio
0.63
Book Value
16.34
Dividend Share
-
Dividend Yield
-
Earnings Share
2.37
Wall Street Target Price
57.34
EPS Estimate Current Year
3.21
EPS Estimate Next Year
3.38
EPS Estimate Current Quarter
0.828
EPS Estimate Next Quarter
0.8383
Most Recent Quarter
-
Revenue TTM
20,995,999,744
Gross Profit TTM
14,526,999,552
EBITDA
5,711,000,064
Profit Margin
17.50%
Return On Assets TTM
6.19%
Return On Equity TTM
15.34%
Revenue Per Share TTM
14.187
Qtly Revenue Growth YOY
7.50%
Diluted Eps TTM
2.37
Qtly Earnings Growth YOY
15.10%
Trailing PE
17.90
Forward PE
13
Price Sales TTM
2.9287
Price Book MRQ
2.6194
Enterprise Value Revenue
3
Enterprise Value EBITDA
13
77.49
2.08%80.05
2.04%23.74
1.98%309.85
1.90%104.41
1.45%96.05
1.07%27.03
0.13%91.66
0.10%27.10
0.00%46.40
-2.10%Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling
Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more
4 stocks to watch on Thursday: VZ, GS, MS, BSX
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments
Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B
Boston Scientific buys Elutia's bioenvelope business for $88 million